Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Electronic Gene Ontology annotations created by ARBA machine learning models
Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor.
-
Experimental or structural characterization involving B2M reported in PMID:10429675.
"The crystal structure of the human class I major histocompatibility complex molecule, human histocompatibility leukocyte antigen (HLA)-Cw4, the ligand for a natural killer (NK) cell inhibitory receptor, has been determined, complexed with a nonameric consensus peptide (QYDDAVYKL)."
The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.
-
Experimental or structural characterization involving B2M reported in PMID:10843695.
"The crystal structure of the human class I MHC molecule HLA-A2 complexed with of an octameric peptide, Tax8 (LFGYPVYV), from human T cell lymphotrophic virus-1 (HTLV-1) has been determined."
Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains.
-
Experimental or structural characterization involving B2M reported in PMID:12118248.
"The human genome encodes five nonpolymorphic major histocompatibility complex class I-like glycoproteins, CD1a to CD1e, that present lipid antigens for specific recognition by T lymphocytes."
Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A.
-
Experimental or structural characterization involving B2M reported in PMID:12833155.
"Here we report the crystal structure of human CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A."
The crystal structure of human CD1b with a bound bacterial glycolipid.
-
Experimental or structural characterization involving B2M reported in PMID:14764708.
"The current crystal structure illustrates for the first time the binding of a natural bacterial lipid Ag to CD1b and shows how its novel structural features fit this molecule for its role in the immune response to intracellular bacteria."
Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.
-
Experimental or structural characterization involving B2M reported in PMID:15718280.
"To gain further insights into HLA-G function, we determined the 1.9-A structure of a monomeric HLA-G complexed to a natural endogenous peptide ligand from histone H2A (RIIPRHLQL)."
Molecular mechanism of lipopeptide presentation by CD1a.
-
Experimental or structural characterization involving B2M reported in PMID:15723809.
"Structure analysis of CD1a cocrystallized with a synthetic mycobactin lipopeptide at 2.8 A resolution further reveals that the single alkyl chain is inserted deep within the A' pocket of the groove, whereas its two peptidic branches protrude along the F' pocket to the outer, alpha-helical surface of CD1a for recognition by the TCR."
The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE protein.
-
Experimental or structural characterization involving B2M reported in PMID:15965644.
"Experiments using cells over-expressing wild-type HFE confirm the existence of beta2microglobulin(beta2m)/HFE and HFE/transferrin receptor 1 (TfR1) interactions, as well as the capacity of HFE to reduce transferrin-mediated iron uptake."
Human colostrum: identification of minor proteins in the aqueous phase by proteomics.
-
Experimental or structural characterization involving B2M reported in PMID:16502470.
"We have investigated the low abundance proteins in the aqueous phase of human colostrum, after depletion of the major proteins secretory IgA, lactoferrin, alpha-lactalbumin and HSA by immunoabsorption, using 2-D LC and gel-based proteomic methods."
3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR.
-
Experimental or structural characterization involving B2M reported in PMID:17108084.
"We have combined solid-state NMR, x-ray fiber diffraction, and atomic force microscopy to reveal the 3D structure of amyloid protofilament-like fibrils formed by a 22-residue K3 peptide (Ser(20)-Lys(41)) of beta(2)-microglobulin, a protein responsible for dialysis-related amyloidosis."
HFE association with transferrin receptor 2 increases cellular uptake of transferrin-bound iron.
-
Experimental or structural characterization involving B2M reported in PMID:18353247.
"The co-expression of HFE in cells expressing TfR2 led to increased affinity for diferric transferrin, increased transferrin-dependent iron uptake, and relative resistance to iron chelation."
Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly.
-
Experimental or structural characterization involving B2M reported in PMID:18579777.
"Using this approach, we have characterized the mechanism of the nucleation-dependent formation of beta(2)-microglobulin (beta(2)m) amyloid fibrils."
The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex.
-
Experimental or structural characterization involving B2M reported in PMID:18802093.
"TAP translocates virus-derived peptides from the cytosol into the endoplasmic reticulum, where the peptides are loaded onto MHC class I molecules."
Large-scale proteomics and phosphoproteomics of urinary exosomes.
-
Experimental or structural characterization involving B2M reported in PMID:19056867.
"Here, we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously, including 177 that are represented on the Online Mendelian Inheritance in Man database of disease-related genes, suggesting that exosome analysis is a potential approach to discover urinary biomarkers."
A regulatable switch mediates self-association in an immunoglobulin fold.
-
Experimental or structural characterization involving B2M reported in PMID:19172750.
"Beta-2 microglobulin (beta2m) is a globular protein that self-associates into fibrillar amyloid deposits in patients undergoing hemodialysis therapy."
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
-
Experimental or structural characterization involving B2M reported in PMID:19199708.
"Using MudPIT (multidimensional protein identification technology) mass spectrometry, we catalogued 491 proteins in the exosome fraction of human parotid saliva."
Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils.
-
Experimental or structural characterization involving B2M reported in PMID:19564620.
"Here, combining these 2 opposing effects on beta(2)-microglobulin (beta2-m), a protein responsible for dialysis-related amyloidosis, we present that ultrasonication pulses are useful for preparing monodispersed amyloid fibrils of minimal size with an average molecular weight of approximately 1,660,000 (140-mer)."
Defining the membrane proteome of NK cells.
-
Experimental or structural characterization involving B2M reported in PMID:19946888.
"The present study was initiated to define the composition of the membrane proteome of the Natural Killer (NK) like cell line YTS."
The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
-
Experimental or structural characterization involving B2M reported in PMID:20164429.
"In this study, we identify a novel mechanism that prevents this self-killing as we show that the association of the MHC class I proteins with the 2B4 receptor, both present on NK cells, results in the attenuation of the 2B4-mediated self-killing of NK cells."
N-glycosylation is important for the correct intracellular localization of HFE and its ability to decrease cell surface transferrin binding.
-
Experimental or structural characterization involving B2M reported in PMID:20618438.
"We also observed that the triple mutant was functionally deficient in beta2-microglobulin interactions and incapable of regulating transferrin binding, once again, reminiscent of the HFE-C282Y variant."
Protein-induced photophysical changes to the amyloid indicator dye thioflavin T.
-
Experimental or structural characterization involving B2M reported in PMID:20826442.
"Here, we report the co-crystal structures of ThT with two alternative states of β-2 microglobulin (β2m); one monomeric, the other an amyloid-like oligomer."
β₂-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages.
-
Experimental or structural characterization involving B2M reported in PMID:21131979.
"Here we show that β₂m can oligomerize and fibrillize via three-dimensional domain swapping. Isolating a covalently bound, domain-swapped dimer from β₂m oligomers on the pathway to fibrils, we were able to determine its crystal structure."
Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant.
-
Experimental or structural characterization involving B2M reported in PMID:21220305.
"The crystal structure of ΔN6β2m in complex with one of these nanobodies (Nb24) identifies domain swapping as a plausible mechanism of self-association of this amyloidogenic protein."
Distinct functions for the glycans of tapasin and heavy chains in the assembly of MHC class I molecules.
-
Experimental or structural characterization involving B2M reported in PMID:21263072.
"Furthermore, the ERp57 binding site and the glycan of tapasin enhance β(2)m and MHC class I heavy (H) chain recruitment to the PLC, with the ERp57 binding site having the dominant effect."
Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.
-
Experimental or structural characterization involving B2M reported in PMID:21423176.
"To determine how focal adhesion composition is affected by myosin II activity, we performed proteomic analysis of isolated focal adhesions and compared protein abundance in focal adhesions from cells with and without myosin II inhibition."
D-strand perturbation and amyloid propensity in beta-2 microglobulin.
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers.
-
Experimental or structural characterization involving B2M reported in PMID:22289140.
"The X-ray structures of DIMC20 and DIMC50 show that the two engineered dimers form a tetrameric assembly; for both tetrameric species, the noncovalent association interface is based on the interaction of facing β2m D-strands and is conserved."
Fibrillogenic propensity of the GroEL apical domain: a Janus-faced minichaperone.
-
Experimental or structural characterization involving B2M reported in PMID:22575645.
"We also found, however, that despite its fibrillation propensity, the apical domain exhibits a pronounced inhibitory effect on the fibril growth of β(2)-microglobulin."
Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.
-
Experimental or structural characterization involving B2M reported in PMID:22664934.
"Herein, we report on an analysis of proteins in the tear fluid from breast carcinoma patients and healthy women using a de novo proteomic approach and 25 mixed samples from each group."
MR1 presents microbial vitamin B metabolites to MAIT cells.
-
Experimental or structural characterization involving B2M reported in PMID:23051753.
"Mucosal-associated invariant T (MAIT) cells are an abundant population of innate-like T cells in humans that are activated by an antigen(s) bound to the MHC class I-like molecule MR1."
Novel antibacterial activity of β(2)-microglobulin in human amniotic fluid.
-
B2M in human amniotic fluid exhibits antibacterial activity against Listeria monocytogenes and Escherichia coli by dissipating bacterial membrane potential.
"Interestingly, the antibacterial action of β(2)M was associated with dissipation of the transmembrane potential, but the protein did not cause damage to the membrane that would result in SYTOX green uptake."
-
LPS stimulation upregulates B2M mRNA expression in WISH amniotic epithelial cells.
"In addition, stimulation of WISH amniotic epithelial cells with the bacterial endotoxin lipopolysaccharide (LPS) induced dose-dependent upregulation of β(2)M mRNA expression."
Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.
-
Experimental or structural characterization involving B2M reported in PMID:23527218.
"In this report, we have identified novel interaction between HLA I and PCNA on the surface of human tumor cells by confocal microscopy and immunoprecipitation."
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
-
Experimental or structural characterization involving B2M reported in PMID:23533145.
"Using expressed prostatic secretions in urine (EPS-urine), exosome preparations were characterized by a shotgun proteomics procedure. In pooled EPS-urine exosome samples, ~900 proteins were detected."
The WT hemochromatosis protein HFE inhibits CD8⁺ T-lymphocyte activation.
-
MHC class I antigen presentation presents endogenous proteins to CD8+ T lymphocytes, and wild-type HFE inhibits antigen-specific CD8+ T-cell activation.
"MHC class I (MHC I) antigen presentation is a ubiquitous process by which cells present endogenous proteins to CD8(+) T lymphocytes during immune surveillance and response."
The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (β2M) affecting antigen presentation function of macrophage.
-
Experimental or structural characterization involving B2M reported in PMID:25356553.
"We found that ESAT-6/ESAT-6:CFP-10 can enter into the endoplasmic reticulum where it sequesters β2M to inhibit cell surface expression of MHC-I-β2M complexes, resulting in downregulation of class I-mediated antigen presentation."
A fluorescent bimolecular complementation screen reveals MAF1, RNF7 and SETD3 as PCNA-associated proteins in human cells.
-
Experimental or structural characterization involving B2M reported in PMID:26030842.
"To fully characterize the set of proteins that interact with PCNA we developed a bimolecular fluorescence complementation (BiFC) screen for PCNA-interactors in human cells."
β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis.
-
Experimental or structural characterization involving B2M reported in PMID:26147761.
"Here we identify β2-microglobulin (B2M), a component of major histocompatibility complex class 1 (MHC I) molecules, as a circulating factor that negatively regulates cognitive and regenerative function in the adult hippocampus in an age-dependent manner."
Breaking bad blood: β2-microglobulin as a pro-aging factor in blood.
The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1.
-
Experimental or structural characterization involving B2M reported in PMID:27043408.
"VitB antigens reach this location and form a Schiff base with MR1, triggering a 'molecular switch' that allows MR1-VitB antigen complexes to traffic to the plasma membrane."
β(2)-Microglobulin participates in development of lung emphysema by inducing lung epithelial cell senescence.
-
B2M is the light chain of MHC class I molecules on nucleated cells and is elevated in alveolar epithelial cells and plasma of emphysema patients.
"β2-Microglobulin (β2M), the light chain of the major histocompatibility complex class I (MHC I), has been identified as a proaging factor and is involved in the pathogenesis of neurodegenerative disorders by driving cognitive and regenerative impairments."
-
Recombinant human B2M and cigarette smoke extract induce cellular senescence in A549 lung epithelial cells.
"Exposure to recombinant human β2M and cigarette smoke extract (CSE) in vitro enhanced cellular senescence and inhibited proliferation of A549 cells, which was partially reversed by the presence of anti-β2M antibody."
Small molecule-mediated inhibition of β-2-microglobulin-based amyloid fibril formation.
-
Experimental or structural characterization involving B2M reported in PMID:28468825.
"Using ion mobility mass spectrometry, we show that both inhibitors promote the compaction of the initially formed β2m dimer, which causes the formation of other off-pathway and amyloid-incompetent oligomers that are isomeric with amyloid-competent oligomers in some cases."
Architecture of the human interactome defines protein communities and disease networks.
-
Experimental or structural characterization involving B2M reported in PMID:28514442.
"Here we present BioPlex 2.0 (Biophysical Interactions of ORFeome-derived complexes), which uses robust affinity purification-mass spectrometry methodology to elucidate protein interaction networks and co-complexes nucleated by more than 25% of protein-coding genes from the human genome, and constitutes, to our knowledge, the largest such network so far."
Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.
-
Experimental or structural characterization involving B2M reported in PMID:28636952.
"The complex structure of peptide-loaded β2m-HLA-F bound to the inhibitory LIR1 revealed similarities to high-affinity recognition of the viral MHC-I mimic UL18 and a docking strategy that relies on contacts with HLA-F as well as β2m, thus precluding binding to HLA-F OCs."
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
-
Experimental or structural characterization involving B2M reported in PMID:32814053.
"Here, we report on an interactome map that focuses on neurodegenerative disease (ND), connects ∼5,000 human proteins via ∼30,000 candidate interactions and is generated by systematic yeast two-hybrid interaction screening of ∼500 ND-related proteins and integration of literature interactions."
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
-
Experimental or structural characterization involving B2M reported in PMID:33961781.
"Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks."
Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes.
-
Experimental or structural characterization involving B2M reported in PMID:35705051.
"MHC-E regulates NK cells by displaying MHC class Ia signal peptides (VL9) to NKG2A:CD94 receptors. MHC-E can also present sequence-diverse, lower-affinity, pathogen-derived peptides to T cell receptors (TCRs) on CD8+ T cells."
Molecular basis of MHC I quality control in the peptide loading complex.
-
Experimental or structural characterization involving B2M reported in PMID:35948544.
"Here, we determine the multi-chaperone-client interaction network of the peptide loading complex (PLC) and report the PLC editing module structure by cryogenic electron microscopy at 3.7 Å resolution."
Structure of an MHC I-tapasin-ERp57 editing complex defines chaperone promiscuity.
Amino acid sequence of a modified beta 2-microglobulin in renal failure patient urine and long-term dialysis patient blood.
-
Experimental or structural characterization involving B2M reported in PMID:7554280.
"We isolated and analyzed beta 2-microglobulin (BM) in urine of two renal failure patients and in ultrafiltrate from long-term dialysis patients."
TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
-
Experimental or structural characterization involving B2M reported in PMID:9427624.
"Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent."
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.
-
Experimental or structural characterization involving B2M reported in PMID:9465039.
"Addition of soluble wild-type HFE/beta2m heterodimers to cultured cells also decreased the apparent affinity of the TfR for its ligand under steady-state conditions, both in 293 cells and in HeLa cells."
Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.
-
Experimental or structural characterization involving B2M reported in PMID:9546397.
"HFE binds to transferrin receptor (TfR) and reduces its affinity for iron-loaded transferrin, implicating HFE in iron metabolism."
Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry.
-
Experimental or structural characterization involving B2M reported in PMID:9892618.
"To examine the mechanism of xeno-reactivity of AHIII12.2, we have determined the crystal structures of A2/p1049 and Db/p1027 to 2.5 A and 2.8 A resolution, respectively."
Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.
-
Experimental or structural characterization involving B2M reported in PMID:9990067.
"Western blots showed that, as was the case in human placenta, the HFE protein in crypt enterocytes is physically associated with the TfR and with beta2-microglobulin."
Expression of IFNG-stimulated genes
-
Reactome pathway step involving B2M (Expression of IFNG-stimulated genes).
"IFN-gamma stimulates gene expression of about 200 genes which include the primary response genes like IRFs, Fc-gamma receptor (FCGR), GBPs (guanylate-binding proteins) and also major histocompatibility complex (MHC) class I and class II molecules, proteins involved in antigen presentation, antiviral proteins like PKR, OAS proteins etc."
Loading of antigen peptide onto MHC class I molecule
-
Reactome pathway step involving B2M (Loading of antigen peptide onto MHC class I molecule).
"Peptides generated by Cathepsin S or IRAP-mediated proteolysis in the endosomes are loaded onto MHC class I molecules, which are internalized and transported to early and late endosomal compartments where antigenic peptides can be loaded."
Trimming of peptides by IRAP in endocytic vesicles
-
Reactome pathway step involving B2M (Trimming of peptides by IRAP in endocytic vesicles).
"While it is established that cathepsin S is involved in antigen processing in endocytotic vesicles, it is less certain whether other proteases present in endocytic vesicles are also involved in generating the peptide fragments."
Translocation of peptide bound MHC class I complex to cell surface
-
Reactome pathway step involving B2M (Translocation of peptide bound MHC class I complex to cell surface).
"Peptide-loaded MHC class I complexes are transported by an undefined mechanism back to the cell surface for cross-presentation to T cells."
Export of peptide loaded MHC class I complex to PM
-
Reactome pathway step involving B2M (Export of peptide loaded MHC class I complex to PM).
"Exogenous antigen loaded class I MHC molecules in phagosomes may be delivered to the surface by membrane recycling machinery."
Formation of MHC I:Nef Complex
-
Reactome pathway step involving B2M (Formation of MHC I:Nef Complex).
"Nef disrupts the transport of major histocompatibility complex class I molecules by first binding to the the cytoplasmic side of the transmembrane complex."
Degradation of MHC I Complex
-
Reactome pathway step involving B2M (Degradation of MHC I Complex).
"Once the complex of Nef, major histocompatibility complex class I molecules, PACS-1 and AP-1 arrives at the endosome, the MHC I complex is targeted for degradation."
Formation of MHC I:Nef:AP-1:PACS-1 Complex
-
Reactome pathway step involving B2M (Formation of MHC I:Nef:AP-1:PACS-1 Complex).
"The complex formed by Nef and the major histocompatibility complex class I molecules creates binding sites for PACS-1 and the AP-1 complex."
Transport of MHC I:Nef:AP-1:PACS-1 Complex
-
Reactome pathway step involving B2M (Transport of MHC I:Nef:AP-1:PACS-1 Complex).
"The complex of Nef, major histocompatibility complex class I molecules, PACS-1 and AP-1 is transported from the trans-Golgi network to an endosome, where the MHC I complex will be degraded."
TCR complex interacts with peptide antigen-presenting MHC Class I
-
Reactome pathway step involving B2M (TCR complex interacts with peptide antigen-presenting MHC Class I).
"T cells distinguish foreign material from self through presentation of fragments of the antigen by the MHC cell surface receptors."
KIR2DL2/3 interacting with HLA-C group 1 (Cw4)
-
Reactome pathway step involving B2M (KIR2DL2/3 interacting with HLA-C group 1 (Cw4)).
"A hallmark of human NK cells is the expression of HLA class I-specific killer-cell immunoglobulin-like receptors (KIR)."
LILRs interact with MHC Class I
-
Reactome pathway step involving B2M (LILRs interact with MHC Class I).
"Leukocyte immunoglobulin (Ig)-like receptors [LILRs, also known as Ig-like transcripts (ILTs)] are a family of inhibitory and stimulatory receptors encoded within the leukocyte receptor complex and are expressed by immune cell types of both myeloid and lymphoid lineage."
KLRC1:KLRD1 heterodimer interacts with HLA-E
-
Reactome pathway step involving B2M (KLRC1:KLRD1 heterodimer interacts with HLA-E).
"After interaction with its ligand HLA-E, which is expressed on normal cells, the C-type lectin inhibitory receptor CD94/NKG2A suppresses activation signaling processes."
MHC Class I interacts with CD160
KIR2DL1 interacting with HLA-C group 2 (Cw3)
-
Reactome pathway step involving B2M (KIR2DL1 interacting with HLA-C group 2 (Cw3)).
"A hallmark of human NK cells is the expression of HLA class I-specific killer-cell immunoglobulin-like receptors (KIR)."
KIR3DL1 interacting with HLA Bw4
KIR3DL2 interacting with HLA-A3
KIR2DL4 interacting with HLA-G
KIR2DS2 interacting with HLA-C group 1 (Cw3)
-
Reactome pathway step involving B2M (KIR2DS2 interacting with HLA-C group 1 (Cw3)).
"A hallmark of human NK cells is the expression of HLA class I-specific killer-cell immunoglobulin-like receptors (KIR)."
KIR2DS1 interacting with HLA-C group 2 (Cw4)
-
Reactome pathway step involving B2M (KIR2DS1 interacting with HLA-C group 2 (Cw4)).
"A hallmark of human NK cells is the expression of HLA class I-specific killer-cell immunoglobulin-like receptors (KIR)."
Recruitment of SYK to p-DAP12
-
Reactome pathway step involving B2M (Recruitment of SYK to p-DAP12).
"Phosphorylated ITAM on DAP12 serves as the docking site for the two SH2 domains of SYK or ZAP70. Binding leads to SYK activation (Lanier et al. 1998, McVicar et al. 1998)."
Interaction of DAP12 and KIR2DS2
-
Reactome pathway step involving B2M (Interaction of DAP12 and KIR2DS2).
"Killer cell immunoglobulin-like two-domain short-tail receptor 2 (KIR2DS2) is an activating KIR receptor invariably expressed on the cell surface of NK cells and subsets of T cells."
DAP12 interacts with NKG2C
-
Reactome pathway step involving B2M (DAP12 interacts with NKG2C).
"NKG2C, a C-type lectin-like surface receptor, is a member of the NKG2 family and forms heterodimers with CD94 that is expressed on NK cells and a subset of T cells."
Interaction of DAP12 and KIR2DS4
-
Reactome pathway step involving B2M (Interaction of DAP12 and KIR2DS4).
"Killer cell immunoglobulin-like two-domain short-tail receptor 4 (KIR2DS4) is the most prevalent lineage III-activating KIR receptor."
Interaction of DAP12 and KIR2DS1
-
Reactome pathway step involving B2M (Interaction of DAP12 and KIR2DS1).
"Killer cell immunoglobulin-like two-domain short-tail receptor 1 (KIR2DS1) is one of the activating KIR receptors expressed on the surface of NK cells."
Phosphorylation of LAT by p-SYK
Phosphorylation of SLP-76 by p-SYK
-
Reactome pathway step involving B2M (Phosphorylation of SLP-76 by p-SYK).
"SLP-76 lacks intrinsic catalytic activity and acts as a scaffold, recruiting other proteins for correct localization during molecular signal transduction (Bogin et al."
PI3K phosphorylates PIP2 to PIP3
-
Reactome pathway step involving B2M (PI3K phosphorylates PIP2 to PIP3).
"Activated PI3K phosphorylates phosphatidylinositol (PI) 4-phosphate and PI 4,5-bisphosphate (PIP2) to generate PI 3,4-bisphosphate and PI 3,4,5-triphosphate (PIP3) and these second messengers recruit other signaling proteins containing plecstrin homology (PH) domain."
p85 regulatory unit of PI3K binds p-6Y-SYK
Phosphorylation of BTK by p-SYK
Phosphorylation and activation of VAV2/VAV3 by SYK
-
Reactome pathway step involving B2M (Phosphorylation and activation of VAV2/VAV3 by SYK).
"VAV exists in an auto-inhibitory state, folded in such a way as to inhibit the GEF activity of its DH domain."
Phosphorylation of PLC-gamma by p-BTK/p-SYK
-
Reactome pathway step involving B2M (Phosphorylation of PLC-gamma by p-BTK/p-SYK).
"Three tyrosine residues at positions 771, 783 and 1254 in PLCgamma1 have been identified as the sites of receptor tyrosine kinase phosphorylation."
Exocytosis of tertiary granule lumen proteins
-
Reactome pathway step involving B2M (Exocytosis of tertiary granule lumen proteins).
"Tertiary (gelatinase) granules are part of a continuum of peroxidase-negative granules formed in myelocytes, metamyelocytes, band cells and segmented neutrophils."
Exocytosis of specific granule lumen proteins
TCR binds self-lipid-based antigen via CD1
-
Reactome pathway step involving B2M (TCR binds self-lipid-based antigen via CD1).
"T lymphocytes have developed the capacity to recognize as antigens a large variety of molecules including peptides, lipids, and vitamin metabolites (Moody DB et al."
TCR binds microbial lipid-based antigen via CD1
-
Reactome pathway step involving B2M (TCR binds microbial lipid-based antigen via CD1).
"The hallmark of T cell activation is the direct binding of T-cell receptor (TCR) to an antigen that is presented by an antigen-presenting molecule."
Fusion of ERC and phagosome
-
Reactome pathway step involving B2M (Fusion of ERC and phagosome).
"Recycling endosome-localized R-SNARE protein like RAB11a, VAMP3, and VAMP8 dock with target phagosome membrane Q-SNARE protein SNAP23."
Loading of antigenic peptides on to class I MHC
-
Reactome pathway step involving B2M (Loading of antigenic peptides on to class I MHC).
"MHC class I heterodimers are only stable in peptide bound form and only as a trimer (with bound peptide) present on the cell surface."
EsxA binds B2M
-
Reactome pathway step involving B2M (EsxA binds B2M).
"Mtb 6 kDa early secretory antigenic target (EsxA) binds to freely available human beta-2-microglobulin (B2M) in the endoplasmic reticulum lumen, inhibiting the loading of antigen-derived peptides to B2M, a component of the class I major histocompatibility complex (MHC-I complex) (Sreejit et al."
SARS-CoV-2 8 binds class I MHC
-
Reactome pathway step involving B2M (SARS-CoV-2 8 binds class I MHC).
"During viral infection, T cells recognize the viral antigens presented by class I MHC."
SARS-CoV-2 8:class I MHC binds BECN1
-
Reactome pathway step involving B2M (SARS-CoV-2 8:class I MHC binds BECN1).
"SARS-CoV-2 ORF8 (8), which has no orthologous protein in SARS-CoV-1 (Li T et al."
Amyloid fibrils have additional components
-
Reactome pathway step involving B2M (Amyloid fibrils have additional components).
"In addition to the main fibril peptide, mature amyloid fibrils have additional components."
Amyloid precursor proteins form ordered fibrils
-
Reactome pathway step involving B2M (Amyloid precursor proteins form ordered fibrils).
"Amyloid fibril formation is associated with a wide range of diseases (Chiti & Dobson 2006), though the accumulation and deposition of fibrillar material does not correlate well with disease pathogenesis and it is now widely believed that oligomeric amyloid forms are largely responsible for the cytotoxic effects of amyloid (Glabe 2009)."
Transport of MHC heterotrimer to ER exit site
-
Reactome pathway step involving B2M (Transport of MHC heterotrimer to ER exit site).
"When the loaded peptide is of a sufficiently high-affinity the trimeric complex is transported to a special ER exit site by a putative cargo receptor, B cell receptor-associated protein (BAP31), where it translocates to the cell surface, possibly by transport in COPII-coated vesicles."
Formation of peptide loading complex (PLC)
-
Reactome pathway step involving B2M (Formation of peptide loading complex (PLC)).
"Upon interaction of Beta-2-microglobin (B2M) with MHC class I Heavy Chain (HC), calnexin is fully replaced by its soluble ortholog calreticulin (CRT) and this complex is incorporated into the peptide loading complex (PLC)."
Interaction of beta-2-microglobulin (B2M) chain with class I HC
-
Reactome pathway step involving B2M (Interaction of beta-2-microglobulin (B2M) chain with class I HC).
"Interaction of calnexin (CNX) with MHC class I HC stabilizes it and facilitates the association of the beta2 microglobulin component (B2M)."
Dissociation of the Antigenic peptide:MHC:B2M peptide loading complex
-
Reactome pathway step involving B2M (Dissociation of the Antigenic peptide:MHC:B2M peptide loading complex).
"Upon peptide binding the class I MHC molecule releases from the peptide loading complex (PLC) and clusters at ER exit sites and is finally exported to the cell surface.<br>MHC I molecules bound to low-affinity peptides are not transferred to the cell surface and are instead cycled back to ER."
Journey of cargo through Golgi complex
Disassembly of COPII coated vesicle
-
Reactome pathway step involving B2M (Disassembly of COPII coated vesicle).
"Before the cargo vesicle can fuse with target membrane, the COPII protein coat must be disassembled and its components released into cytosol."
Budding of COPII coated vesicle
-
Reactome pathway step involving B2M (Budding of COPII coated vesicle).
"Once the entire COPII coat has been assembled, the bud is separated from the ER membrane in the form of a COPII coated vesicle."
Recruitment of Sec31p:Sec13p to prebudding complex and formation of COPII vesicle
-
Reactome pathway step involving B2M (Recruitment of Sec31p:Sec13p to prebudding complex and formation of COPII vesicle).
"Sec13-Sec31 binds the prebudding complex and this Sec13-Sec31 heterotetramer forms the outer structural scaffold of the coat. Sec13-Sec31 is likely to crosslink the prebudding complexes generating COPII-coated vesicles."
Capturing cargo and formation of prebudding complex
Expression of peptide bound class I MHC on cell surface
-
Reactome pathway step involving B2M (Expression of peptide bound class I MHC on cell surface).
"After passing through the Golgi complex, secretory cargo is packaged into post-Golgi transport intermediates (post-Golgi), which translocate plus-end directed along microtubules to the plasma membrane."
UniProtKB/Swiss-Prot entry P61769 (B2MG_HUMAN)
-
B2M is the invariant beta-chain component of MHC class I complexes involved in peptide antigen presentation.
"Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system."
-
B2M forms heterotrimers with non-classical MHC class Ib molecules (HLA-E, HLA-F, HLA-G) and MR1.
"Forms a heterotrimer with HLA-E and a self- or a foreign peptide (PubMed:9427624). Forms a heterotrimer with HLA-G and a self-peptide (PubMed:17056715). Forms a heterotrimer with HLA-F and a self-peptide (PubMed:10605026). Forms a heterotrimer with MR1 and a metabolite antigen."
-
B2M localizes to the cell surface and is secreted into serum and urine.
"Secreted. Cell surface. Note=Detected in serum and urine (PubMed:1336137, PubMed:7554280)."